TABLE 1.
First author and year | Type of study | Setting | Country | Study period | Number of participants | Definition of T1DM | Fracture ascertainment | Age (y) | Total fracture events (fractured/total) | Fracture type | Fracture events by gender in those aged between 18–50 years (fractured/total) | OR/RR/HR | Variables adjusted | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zhukouskaya et al., 201320 | Cross-sectional | Hospital outpatient | Belarus | 2007–2011 | 82 T1DM (26M:56F); 82 controls (22M:60F) | American Diabetes Association criteria | Vertebral fracture assessment and spinal radiographs | 20–55 | 20/82 of T1DM vs 5/82 of controls | Vertebral | Males: 6/26 T1DM; 1/22 controls | Females: 14/56 T1DM; 4/60 controls | OR 4.20, 95% Cl 1.40–12.70, P < .01 | Age, sex, BMI, lumbar spine BMD |
Weber et al., 201514 | Prospective cohort | Population | UK | 1994–2002 | Total 30 394 T1DM (17 074M:13 347F); 303 872 controls (170 421M:133 451F) | Medical diagnoses (read codes) specific to T1DM or diabetes and <35 years old | Diagnosis codes from outpatient electronic medical records consistent with incident fracture, classified by site; surgically-induced fractures or those associated with birth trauma or metastases were excluded | 0–89 | 2615/30 394 of T1DM vs 18 624/30 3872 of controls | Any fracture | Males: 779/10 874 T1DM; 5367/109 016 controlsa | Females: 431/8193 T1DM; 2440/82 156 controlsa | Males: HR 1.55, 95% Cl 1.44–1.67, P < .001a; Females: 1.76 95% Cl 1.58–1.96, P < .001a | Steroid use, prior fracture, CKD |
Hip | Males: 21/10 983 T1DM; 75/109 927 controlsa | Females: 14/8321 T1DM; 28/82 390 controlsa | Males: HR 2.55, 95% Cl 1.52–4.26, P < .001a; Females: HR 3.36, 95% Cl 1.61–7.10, P = .001a | |||||||||||
Hothersall et al., 201416 | Retrospective cohort study | Population/registry-based | Scotland | 2005–2007 | 21 033 T1DM/59 585 person-years; controls 3.66million/10 980 599 person-years | Clinical and prescription history (no evidence of lengthy diabetes duration prior to insulin prescription, no co-prescription of oral anti-diabetic drugs except for metformin) | Incident hip fracture admissions in 2005 to 2007 by linkage of diabetes register to national hospital admissions data (ICD codes) | 20–84 | 105/21 033 of T1DM vs 11 733/36 60000 of controls | Hip | Males: 14/8844 of T1DM; 331/1026 350 of controlsb | Females: 7/6649 of T1DM; 160/107 6510 of controlsb | Males: RR 5.4, 95% CI 3.5–8.3, P < .001b; Females: RR 7.9, 95% Cl 3.4–18.5, P < .001b | Age, sex and calendar year |
Vestergaard et al., 200919 | Case-control | Population | Denmark | 2000 | 4369 T1DM, 484 615 controls | WHO standards | National Hospital Discharge Register & ICD codes | 43 ± 27 | 1703/4369 of T1DM vs 122 952/371 296 of controls | Any fracture | Males: 284/797 of T1DM; 26 201/105 458 of controlsc | Females: 139/344 of T1DM; 13 677/55 132 of controlsc | Males: OR 1.67, 95% Cl 1.45–1.94, P < .001c; Females: OR 2.06, 95% Cl 1.66–2.55, P < .001c | Macro- and micro-vascular complications |
Danielson et al., 200921 | Matched, nested cross-sectional | Population | USA | 2005 | T1DM females 75; controls 75 | New cases of T1DM defined as diagnosis ≤age 30, clinical symptoms of hyperglycaemia and insulin-requiring | Self-reported fractures confirmed by physician or radiograph | 18–50 | Fracture: 28 T1DM, 18 controls | Any | N/A | Females: 28/75 of T1DM; 18/75 of controls | Females: OR 2.3, 95% Cl 1.0–5.2, P < .05 | Not reported |
Strotmeyer et al., 200622 | Cross-sectional | Population (volunteer subgroup from prospective study) | USA | Un-known | T1DM females 67; controls 237 | Premenopausal women on diabetes registry diagnosed at age <17 years in hospital | Self-reported | 35–55 | Fracture: T1DM 33.3% vs controls 22.6%, age-adjusted OR 1.89 (95% Cl 1.02–3.49) | Any fracture after age 20 (site not specified) | N/A | Females: 22/67 of T1DM; 54/237 of controls | Females: OR 1.89, 95% Cl 1.02–3.49, P > .05 | Age |
BMD, bone mineral density; T1DM, type 1 diabetes mellitus.
Part of a secondary analysis of dataset initially assembled to describe fracture incidence from birth to 89 years, using data from The Health Improvement Network; data obtained from investigators through personal communication.
Part of a secondary analysis of original data set; data obtained from investigators through personal communication.
Part of a secondary analysis of original data set; data obtained from investigators through personal communication.